March 18, 2014
By Edgar
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Kate Tillan
Assistant Chief Accountant
Re: Mesa Laboratories, Inc. (the “Company”)
Form 10-K for Fiscal Year Ended March 31, 2013
Filed June 6, 2013
File No. 000-11740
Dear Ms. Tillan:
Mesa Laboratories, Inc. is filing this Correspondence in response to the Staff’s comment letter dated March 13, 2014 (the “Comment Letter”). The response which follows corresponds to the one comment in the Comment Letter.
Form 10-K for the Fiscal Year Ended March 31, 2013
Item 8. Financial Statements
Note 1. Description of Business and Summary of Significant Accounting Policies
Revenue Recognition, page 29
1. In future filings, we will separately disclose the related costs of service pursuant to Rule 5-03(b)(2) of Regulation S-X. In addition, in future filings, we will revise our disclosure to include our revenue recognition policy for all significant components of revenues.
We appreciate your prompt review of our prior submission and are hopeful that the Staff can expedite its review of this submission and, thereafter, confirm to us that it will not have any further comments on our Form 10-K for the fiscal year ended March 31, 2013.
Mesa Laboratories Inc. 12100 W. 6th Ave. Lakewood, CO 80228 USA
(303) 987-8000 FAX (303) 987-8989 www.mesalabs.com Symbol “MLAB” on the NASDAQ